# Omnipulse Biosciences, Inc. — Form D

Omnipulse Biosciences, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-02. The offering totals $12.5M, of which $7.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-01-02
- Form: D
- Accession: 0001976713-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.5M
- Amount sold: $7.0M
- Remaining: $5.5M
- Investors: 2
- Date of first sale: 2023-12-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-501260

## Issuer

- Name: Omnipulse Biosciences, Inc.
- CIK: 0001976713
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 238 Main Street, Cambridge, MA, 02142
- Phone: 978-999-2040

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Robert Farra | Director | Cambridge, MA |
| Felicia Hsu | Director | Cambridge, MA |
| Ana Jacklenec | Director | Cambridge, MA |
| Robert Langer | Director | Pittsburgh, PA |
| David Zhu | Director | San DIego, CA |
| Robert Farra | Executive Officer | Cambridge, MA |
| Joseph DeSimone | Promoter | DURHAM, NC |
| Ana Jacklenec | Promoter | Cambridge, MA |
| Robert Langer | Promoter | Pittsburgh, PA |

## More

- [CIK 1976713 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1976713&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001976713-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.